TY  - JOUR
PY  - 1989//
TI  - Cost analysis of osteoporosis related to untreated menopause
JO  - Clinical rheumatology
A1  - Levy, E.
SP  - 76
EP  - 82
VL  - 8 Suppl 2
IS  - 
N2  - Menopausal osteoporosis has many consequences for women over 50. Its complications incur high treatment costs both for society and the patients themselves. Collection of the epidemiological data required for a cost analysis of menopause-related osteoporosis is not easy, but we have calculated the direct (i.e. purely medical) costs as follows: hip fractures: approximate number per annum in women over 50: 55,000, minimum hospital costs (treatment and rehabilitation): 3.5 bn FF; forearm fractures: approximate number per annum: 35,000, cost of out-patient treatment: 200 m FF; vertebral fractures: common, but generally unrecorded: estimated number 40,000-65,000 cost: unevaluated. The relative benefit of hormone therapy versus nontreatment may be used to calculate the cost of osteoporosis due to non treated menopause. In France, where currently only 5% women over 50 are treated, this cost is 2.2 bn FF. If 50% of women were treated, the savings from hormone therapy (in terms of osteoporosis treatment costs) could be 1.2 bn FF, a figure which must be weighed against a cost analysis of oestrogen therapy.<p /> <p>Language: en</p>
LA  - en
SN  - 0770-3198
UR  - http://dx.doi.org/
ID  - ref1
ER  -